Article
Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkers
20 Jan 2023
Abstract excerpt
Prostate cancer is the second most common male cancer worldwide showing the highest rates of incidence in Western Europe. Although the measurement of serum prostate-specific antigen levels is the current gold standard in PCa diagnosis, PSA-based screening is not considered a reliable diagnosis and prognosis tool due to its lower sensitivity and poor predictive score which lead to a 22%-43% overdiagnosis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
